This company listing is no longer active
Aceragen Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
John Taylor
Chief executive officer
US$444.1k
Total compensation
CEO salary percentage | 17.5% |
CEO tenure | less than a year |
CEO ownership | n/a |
Management average tenure | 4.2yrs |
Board average tenure | 4.4yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Mar 31 2023 | n/a | n/a | -US$41m |
Dec 31 2022 | US$444k | US$78k | -US$23m |
Compensation vs Market: John's total compensation ($USD444.06K) is about average for companies of similar size in the German market ($USD438.32K).
Compensation vs Earnings: Insufficient data to compare John's compensation with company performance.
CEO
John Taylor (52 yo)
less than a year
Tenure
US$444,062
Compensation
Mr. John C. Taylor serves as President, Chief Executive Officer and Director since September 28, 2022 at Aceragen, Inc. He was Chief Executive Officer of Spyryx Biosciences, Inc since December 2013 and ser...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
President | less than a year | US$444.06k | no data | |
Associate Director of Human Resources | no data | no data | no data | |
Director of Human Resources | no data | no data | no data | |
Senior Vice President of Technical Operations | no data | no data | no data | |
Global Head of Quality | no data | no data | no data | |
Medical Director & Global Clinical Lead for Oncology | no data | no data | no data | |
Advisor | 4.2yrs | US$993.93k | no data | |
Adviser | no data | US$986.13k | no data |
4.2yrs
Average Tenure
62yo
Average Age
Experienced Management: V9Z's management team is considered experienced (4.2 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
President | less than a year | US$444.06k | no data | |
Independent Director | 4.4yrs | US$89.43k | 0.26% € 5.3k | |
Chair of the Board of Directors | 8.8yrs | US$1.43m | 0.10% € 2.0k | |
Independent Director | less than a year | US$11.88k | no data | |
Independent Director | 7.7yrs | US$66.24k | 0% € 0 | |
Independent Director | 4.4yrs | US$60.12k | 0% € 0 | |
Member of Scientific Advisory Board | no data | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Member of Scientific Advisor Board | no data | no data | 14.31% € 289.2k |
4.4yrs
Average Tenure
63.5yo
Average Age
Experienced Board: V9Z's board of directors are considered experienced (4.4 years average tenure).
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2023/09/05 20:06 |
End of Day Share Price | 2023/08/30 00:00 |
Earnings | 2023/03/31 |
Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Aceragen, Inc. is covered by 11 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Michael Ulz | Baird |
Huidong Wang | Barclays |
Michael King | JMP Securities |